• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jclinpathJournal of Clinical PathologyCurrent TOCInstructions for authors
J Clin Pathol. Jul 1991; 44(7): 573–575.
PMCID: PMC496797

Prealbumin in the diagnosis of bronchopulmonary carcinoid tumours.

Abstract

The reliability of prealbumin as a diagnostic marker was studied in 60 cases of bronchopulmonary carcinoid tumours. There were differences in the incidence of positivity between typical and atypical carcinoids (well differentiated neuroendocrine carcinomas). Seventy five per cent of the carcinoid tumours were positive for prealbumin; (86.7% typical and 63.3% atypical carcinoids). In 15 cases, which were Grimelius negative, 10 were prealbumin positive. Only 8.3% carcinoids were negative with both prealbumin and Grimelius stains. Ten squamous, 10 adeno- and 10 small cell carcinomas showed only occasional scattered prealbumin positive cells. It is concluded that prealbumin is a useful marker for bronchopulmonary carcinoid tumours. It is cheap, readily available, and should be considered part of routine diagnostic procedures for the diagnosis of carcinoid tumours.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (794K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Miller ID, Reid WA, Liddle CN, Horne CH. Immunolocalization of prealbumin as a marker for carcinoid tumours. J Pathol. 1984 Jul;143(3):199–204. [PubMed]
  • Bussolati G, Papotti M, Sapino A. Binding of antibodies against human prealbumin to intestinal and bronchial carcinoids and to pancreatic endocrine tumours. Virchows Arch B Cell Pathol Incl Mol Pathol. 1984;45(1):15–22. [PubMed]
  • Hasleton PS, Gomm S, Blair V, Thatcher N. Pulmonary carcinoid tumours: a clinico-pathological study of 35 cases. Br J Cancer. 1986 Dec;54(6):963–967. [PMC free article] [PubMed]
  • Blondal T, Grimelius L, Nou E, Wilander E, Aberg T. Argyrophil carcinoid tumors of the lung. Incidence, clinical study, and follow-up of 46 patients. Chest. 1980 Dec;78(6):840–844. [PubMed]
  • Bergh J, Esscher T, Steinholtz L, Nilsson K, Påhlman S. Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers. Am J Clin Pathol. 1985 Jul;84(1):1–7. [PubMed]
  • Walts AE, Said JW, Shintaku IP, Lloyd RV. Chromogranin as a marker of neuroendocrine cells in cytologic material--an immunocytochemical study. Am J Clin Pathol. 1985 Sep;84(3):273–277. [PubMed]
  • al-Saffar N, White A, Moore M, Hasleton PS. Immunoreactivity of various peptides in typical and atypical bronchopulmonary carcinoid tumours. Br J Cancer. 1988 Dec;58(6):762–766. [PMC free article] [PubMed]
  • Grote TH, Macon WR, Davis B, Greco FA, Johnson DH. Atypical carcinoid of the lung. A distinct clinicopathologic entity. Chest. 1988 Feb;93(2):370–375. [PubMed]
  • Linnoila RI, Mulshine JL, Steinberg SM, Funa K, Matthews MJ, Cotelingam JD, Gazdar AF. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas. Am J Clin Pathol. 1988 Dec;90(6):641–652. [PubMed]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...